vs

Side-by-side financial comparison of SMITH MICRO SOFTWARE, INC. (SMSI) and Vivos Therapeutics, Inc. (VVOS). Click either name above to swap in a different company.

SMITH MICRO SOFTWARE, INC. is the larger business by last-quarter revenue ($4.0M vs $3.8M, roughly 1.0× Vivos Therapeutics, Inc.). On growth, Vivos Therapeutics, Inc. posted the faster year-over-year revenue change (3.4% vs -20.0%). Over the past eight quarters, Vivos Therapeutics, Inc.'s revenue compounded faster (5.8% CAGR vs -17.2%).

Smith Micro Software, Inc., founded in 1982 by William W. Smith, Jr., is a developer and marketer of both enterprise and consumer-level software and services. Headquartered in Pittsburgh, Pennsylvania, Smith Micro maintains multiple domestic and international offices. United States locations include Aliso Viejo, California, and Pittsburgh, Pennsylvania. International offices are located throughout Europe and Asia. Currently, the company focuses on digital lifestyle solutions and security tech...

Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts. In the development of therapies, the company relies on CRISPR base editing and prime editing, whereby single nucleotides in a DNA sequence can be enzymatically modified without producing double-strand breaks.

SMSI vs VVOS — Head-to-Head

Bigger by revenue
SMSI
SMSI
1.0× larger
SMSI
$4.0M
$3.8M
VVOS
Growing faster (revenue YoY)
VVOS
VVOS
+23.4% gap
VVOS
3.4%
-20.0%
SMSI
Faster 2-yr revenue CAGR
VVOS
VVOS
Annualised
VVOS
5.8%
-17.2%
SMSI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
SMSI
SMSI
VVOS
VVOS
Revenue
$4.0M
$3.8M
Net Profit
$-6.9M
Gross Margin
76.4%
78.1%
Operating Margin
-109.8%
-166.8%
Net Margin
-180.3%
Revenue YoY
-20.0%
3.4%
Net Profit YoY
-143.8%
EPS (diluted)
$-0.15
$-0.58

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SMSI
SMSI
VVOS
VVOS
Q4 25
$4.0M
$3.8M
Q3 25
$4.3M
$6.8M
Q2 25
$4.4M
$3.8M
Q1 25
$4.6M
$3.0M
Q4 24
$5.0M
$3.7M
Q3 24
$4.6M
$3.9M
Q2 24
$5.1M
$4.1M
Q1 24
$5.8M
$3.4M
Net Profit
SMSI
SMSI
VVOS
VVOS
Q4 25
$-6.9M
Q3 25
$-4.5M
$-5.4M
Q2 25
$-15.1M
$-5.0M
Q1 25
$-5.2M
$-3.9M
Q4 24
$-2.8M
Q3 24
$-6.4M
$-2.6M
Q2 24
$-6.9M
$-1.9M
Q1 24
$-31.0M
$-3.8M
Gross Margin
SMSI
SMSI
VVOS
VVOS
Q4 25
76.4%
78.1%
Q3 25
73.9%
58.0%
Q2 25
73.5%
55.2%
Q1 25
72.8%
50.0%
Q4 24
75.6%
56.7%
Q3 24
71.6%
60.5%
Q2 24
68.7%
65.4%
Q1 24
65.7%
56.7%
Operating Margin
SMSI
SMSI
VVOS
VVOS
Q4 25
-109.8%
-166.8%
Q3 25
-103.2%
-69.8%
Q2 25
-338.3%
-127.4%
Q1 25
-112.7%
-129.9%
Q4 24
-89.7%
-75.9%
Q3 24
-140.0%
-68.5%
Q2 24
-135.8%
-47.8%
Q1 24
-542.4%
-110.7%
Net Margin
SMSI
SMSI
VVOS
VVOS
Q4 25
-180.3%
Q3 25
-104.3%
-79.6%
Q2 25
-340.8%
-131.2%
Q1 25
-112.1%
-128.1%
Q4 24
-76.4%
Q3 24
-137.0%
-67.8%
Q2 24
-134.8%
-47.6%
Q1 24
-534.8%
-110.1%
EPS (diluted)
SMSI
SMSI
VVOS
VVOS
Q4 25
$-0.15
$-0.58
Q3 25
$-0.25
$-0.49
Q2 25
$-0.78
$-0.55
Q1 25
$-0.28
$-0.45
Q4 24
$0.54
$0.41
Q3 24
$-0.54
$-0.40
Q2 24
$-0.66
$-0.60
Q1 24
$-3.28
$-1.63

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SMSI
SMSI
VVOS
VVOS
Cash + ST InvestmentsLiquidity on hand
$1.5M
$2.0M
Total DebtLower is stronger
$2.9M
Stockholders' EquityBook value
$18.4M
$-1.5M
Total Assets
$25.0M
$25.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SMSI
SMSI
VVOS
VVOS
Q4 25
$1.5M
$2.0M
Q3 25
$1.4M
$3.1M
Q2 25
$1.4M
$4.4M
Q1 25
$2.3M
$2.3M
Q4 24
$2.8M
$6.3M
Q3 24
$1.5M
$6.3M
Q2 24
$5.6M
$6.9M
Q1 24
$6.2M
$2.6M
Total Debt
SMSI
SMSI
VVOS
VVOS
Q4 25
$2.9M
Q3 25
Q2 25
Q1 25
Q4 24
$1.2M
Q3 24
$1.2M
Q2 24
$1.2M
Q1 24
Stockholders' Equity
SMSI
SMSI
VVOS
VVOS
Q4 25
$18.4M
$-1.5M
Q3 25
$19.9M
$2.5M
Q2 25
$22.4M
$4.6M
Q1 25
$36.6M
$4.4M
Q4 24
$40.8M
$8.0M
Q3 24
$37.7M
$7.7M
Q2 24
$42.9M
$6.3M
Q1 24
$45.4M
$582.0K
Total Assets
SMSI
SMSI
VVOS
VVOS
Q4 25
$25.0M
$25.2M
Q3 25
$27.1M
$25.6M
Q2 25
$29.6M
$26.0M
Q1 25
$43.4M
$11.3M
Q4 24
$48.0M
$15.3M
Q3 24
$46.2M
$15.3M
Q2 24
$53.0M
$15.8M
Q1 24
$55.4M
$11.8M
Debt / Equity
SMSI
SMSI
VVOS
VVOS
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.15×
Q3 24
0.16×
Q2 24
0.19×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SMSI
SMSI
VVOS
VVOS
Operating Cash FlowLast quarter
$-2.2M
$-3.8M
Free Cash FlowOCF − Capex
$-5.3M
FCF MarginFCF / Revenue
-139.7%
Capex IntensityCapex / Revenue
40.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-17.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SMSI
SMSI
VVOS
VVOS
Q4 25
$-2.2M
$-3.8M
Q3 25
$-2.1M
$-4.2M
Q2 25
$-2.3M
$-3.5M
Q1 25
$-602.0K
$-3.8M
Q4 24
$-4.9M
$-2.9M
Q3 24
$-3.8M
$-4.2M
Q2 24
$-4.2M
$-3.0M
Q1 24
$-1.3M
$-2.5M
Free Cash Flow
SMSI
SMSI
VVOS
VVOS
Q4 25
$-5.3M
Q3 25
$-2.2M
$-4.2M
Q2 25
$-4.3M
Q1 25
$-606.0K
$-3.9M
Q4 24
$-4.9M
$-3.1M
Q3 24
$-3.8M
$-4.4M
Q2 24
$-4.2M
$-3.1M
Q1 24
$-1.3M
$-2.7M
FCF Margin
SMSI
SMSI
VVOS
VVOS
Q4 25
-139.7%
Q3 25
-49.6%
-62.6%
Q2 25
-111.6%
Q1 25
-13.1%
-129.9%
Q4 24
-99.2%
-84.0%
Q3 24
-82.2%
-113.4%
Q2 24
-82.0%
-76.7%
Q1 24
-23.3%
-78.0%
Capex Intensity
SMSI
SMSI
VVOS
VVOS
Q4 25
40.0%
Q3 25
0.5%
1.2%
Q2 25
20.2%
Q1 25
0.1%
4.0%
Q4 24
0.1%
4.5%
Q3 24
0.1%
5.0%
Q2 24
0.1%
1.5%
Q1 24
0.1%
4.4%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

SMSI
SMSI

Family Safety$3.2M80%
Other$797.0K20%

VVOS
VVOS

Services$3.2M84%
Products$594.0K16%

Related Comparisons